DNAhelicase is essential in the processes of DNA replication, repair, recombination and transcription by unwinding of double-stranded DNAto its reactive single strand form. This is an energy requiring process driven by the hydrolysis of deoxynucleaside S'-triphosphate1*.
All knownDNAhelicases have been found to process intrinsic DNA-dependent ATPase activity2~4).
DNAhelicase was discovered for the first time in 1976 in E. coli5). Most of the DNAhelicases need SSDNA adjacent to the duplex region to be unwound, with the notable exception of the SV40 T antigen6), E. coli helicase7) , and E. coli Rec8) which are also able to unwind fully duplex linear DNA. In the course of screening for inhibitors of DNA helicase, we discovered a novel compoundnamed heliquinomycin from the culture broth of Streptomyces sp. . In this communication, we report the taxonomyof the producing culture as well as the fermentation, production, isolation, physico-chemical properties and biological activities of heliquinomycin. Determination of heliquinomycin structure will be described in the following paper9).
Materials and Methods

Microorganism
The heliquinomycin producting organism, strain MJ929-SF2 was isolated from a soil sample collected at Hachiohji, Tokyo, Japan and has been deposited in the Partial Purification of HumanDNAHelicase DNAhelicase was prepared from HeLa cells. The logarithmically growing cells were collected and stocked at -80°C. The frozen cells were thawed on ice, and a nuclear extract fraction was prepared as described by Dignam et al.10\ Briefly, the nuclear extract protein was precipitated by slow addition of ammonium sulfate (0.35g/ml) with constant stirring. The mixture was stirred for an additional hour and the precipitate was 2niM ATP; 10mM KC1; 4% (wt/vol) sucrose; 80jUg/ml BSA; 32P-labelled helicase substrate (1000 cpm) and the helicase fraction, was incubated at 37°C for 20 minutes.
The reaction was terminated by the addition of 0.06% SDS, 2niM EDTA, 1% glycerol and 0.02mg/ml bromophenol blue at the final concentration. After further incubation at 37°C for 5minutes the substrate and product were separated by electrophoresis on a 12% nondenaturing polyacrylamid gel. The gel was dried under vacuum and exposed to Hyperfilm with an intensifying screen for autoradiography. The IC50 value is the concentration of inhibitor at 50% inhibition of enzymeactivity.
Fermentation
The strain, MJ929-SF2, was inoculated into 1 10ml of seed culture medium consisting of galactose 2.0%; dextrin 2.0%; Bacto Soytone 1.0%; corn steep liquor 0.5%; (NH4)2SO4 0.2% and CaCO3 0.2% (pH 7.4) in a 500-ml Erlenmeyer flask, and cultured by incubating at 27°C for 4days on a rotary shaker (180rpm). Two ml of this seed culture were inoculated into 110ml of the same medium in a 500-ml Erlenmeyer flask and in-C for 4days on a rotary shaker (180rpm).
Isolation
The culture broth was separated into mycelial cake and culture filtrate by filtration. The mycelial cake was extracted with methanol. The extract was filtered and concentrated in vacuo to an aqueous solution. The solution was combined with the culture filtrate and extracted with an equal volume of butyl acetate. The active extract was concentrated to dryness under reduced pressure. The dried material was chromatographed on a silica gel column (x50 w/w powder) with a linear gradient 0 to 100% aqueous MeOH. The active fractions were collected and evaporated to give a red powder. The powderwas subjected to centrifungal partition chromatography using CPC-L.L.N model NMF(Sanki Engineering Limited) with a solvent system of CHC13-MeOH- 
Antimicrobial Activity
The minimum inhibitory concentrations (MIC) of heliquinomycin were examined by serial agar dilution method using Mueller Hinton agar (Difco) for an antibacterial test which was incubated at 37°C for 18hours11}.
Antitumor Activity
Tumor cells were incubated in 96-well plate for 24 hours prior to the addition of heliquinomycin into culture well at varied concentrations. After 2 to 3 days incubation at 37°C, MTTreagent was added and further incubated for 4hours. Growth inhibition activity was determined according to the standard MTT assay method12) and IC50 was calculated. produced. The physiological properties of the strain MJ929-SF2 are summarized in Table 2 . Utilization of carbon source by this strain is presented in Table 3 . Analysis of the whole-cell hydrolysate of the strain indicated the presence of LL-diaminopimelic acid. On the basis of the characterisitics described above, the strain MJ929-SF2 is assessed to belong to the genus Strep tomyces. Mycelial growth was expressed as packed cell volume obtained after centrifugation of 10ml of the culture broth at 2,000 rpm for 10minutes. 755 1-propanol and n-hexane. The UVspectrum of heliquinomycin were similar to those of griseprhodins13). Biological Activities of Heliquinomycin In order to determine the inhibition kinetics to DNA helicase by heliquinomycin, the concentrations of enzyme substrate and heliquinomycin were varied in the reaction mixture. As shown in Fig. 5 , inhibition of heliquinomycin against DNAhelicase was in a noncompetitive manner. Its Ki value was determined to be 6.8jum. The antimicrobial activities of heliquinomycin were also examined and the results are shown in Table 5 . Heliquinomycin showed strong inhibitory activity against Gram-positive bacteria strains including methicillin-resistant strains, but not against Gram-negative organisms or fungi.
The antitumor activity of heliquinomycin against tumor cell lines listed in Table 6 was examined. Heliquinomycin exhibited the growth inhibitory effect on several tumor cell lines. The concentrations inhibiting O 13ug/ml, a 6.5jug/ml, à" 3.25/zg/ml, å O^g/ml.
Inhibition of DNAhelicase activity by heliquinomycin at various concentration wasmeasuredwherethe amount of enzyme substrate of 32P-labeled annealing circular DNA was varied.
Thus obtained inhibition kinetics of heliquinomycin were analyzed by the Lineweaver-burk plot and showed to be the mixed type of inhibition. 50% of growth (IC50) are shown in Table 6 .
Heliquinomycin was discovered to be an inhibitor of DNAhelicase, which is thought to be essential for DNA replication, repair, transcription and recombination. It showed antimicrobial and antitumor activity in vitro.
Weare now preparing to demonstrate whether heli- Growth inhibition activity was determined according to the MTTassay method.
